Related Experiment Video

Updated: Aug 8, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

Pediatric inflammatory bowel disease

Karen-A Diefenbach1, Christopher-K Breuer

  • 1Department of Surgery, Yale University School of Medicine, Division of Pediatric Surgery, 330 Cedar Street, Rm. 132 FMB, North Haven, CT 06520, USA.

World Journal of Gastroenterology
|May 24, 2006
PubMed

Insights

Pediatric inflammatory bowel disease (IBD) is rising, requiring prompt diagnosis and tailored management. Treatment focuses on remission, growth, and addressing psychosocial needs in children and adolescents.

Area of Science:

  • Pediatric Gastroenterology
  • Gastrointestinal Pathology
  • Inflammatory Bowel Disease Research

Background:

  • Inflammatory bowel disease (IBD) is a growing cause of gastrointestinal issues in children and adolescents.
  • Increasing incidence necessitates clinician awareness of pediatric IBD presentation.
  • Accurate diagnosis and differentiation between Crohn's disease and ulcerative colitis are crucial.

Purpose of the Study:

  • To review the diagnosis and management of pediatric inflammatory bowel disease.
  • To highlight the importance of growth and psychosocial well-being in affected children.
  • To present diagnostic and treatment algorithms for pediatric IBD.

Main Methods:

  • Review of diagnostic modalities including laboratory tests, radiology, and endoscopy.
  • Discussion of medical management strategies aimed at inducing remission and minimizing side effects.
  • Outline of indications for surgical intervention in pediatric IBD.
  • Exploration of psychosocial aspects and future research directions.

Main Results:

  • Diagnostic tools aid in identifying IBD and distinguishing between Crohn's disease and ulcerative colitis.
  • Medical management focuses on remission and normal growth, with surgery reserved for specific cases.
  • Psychosocial factors are significant considerations in the comprehensive care of pediatric IBD patients.

Conclusions:

  • Effective management of pediatric inflammatory bowel disease requires a multi-faceted approach.
  • Early diagnosis, appropriate medical or surgical treatment, and attention to growth and psychosocial health are paramount.
  • Continued research is essential to address the complexities of pediatric IBD.

Related Concept Videos

Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...